The next set of investor relations (IR) questions and responses from biotechs provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock. This round of responses (received between September 2012 and January 2013) [...]
Tags
Comments
Log in to leave a comment

